Change in number of shares in Brighter AB.

Conversion of convertible notes into shares under the Convertible Notes issued under the financing agreement announced on April 26.

Change in handling of information regarding the L1 Capital financing.  Brighter will in future transactions within the present agreement with L1 Capital, not send any press releases. Current information will instead be published on the website under the following link.  https://brighter.se/en/investors/financing-through-l1-capital/

The number of Notes converted on January 19th, 2018 was 18. The number of Notes remaining under the fourth Tranche for future conversion is 82. The number of shares and the number of votes before the conversion was 64,964,545. Through the conversion, the number of shares and the number of votes have increased by 200,892. The total number of shares and the total number of votes after the conversion amount to 65,165,437.

For terms and conditions of the Notes, please visit: http://brighter.se/en/investors/documents/.

For more information, please contact:

Truls Sjöstedt, CEO            
Tel: +46 709 73 46 00            
Email: truls.sjostedt@brighter.se

Ann Zetterberg, CFO            
Tel: +46 708 37 21 23           
Email: ann.zetterberg@brighter.se

About Brighter AB
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of the most serious healthcare problems: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop™ - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and close associates, healthcare providers, research, pharmaceutical industry and society. www.brighter.se

The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Remium Nordic Holding AB +46 (0)8 – 454 32 50, CorporateFinance@remium.com, www.remium.com.

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 09:15 CET on January 22, 2018.

About Us

Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and its first innovative tool Actiste®, the company creates a more efficient care chain with focus on the individual. Brighter is initially focused on diabetes care, but there are opportunities in the future to operate on a broader level, spanning more diseases and treatment approaches. This is done through The Benefit Loop®, Brighter’s cloud-based service that continuously collects, analyzes and shares data on the user's terms.

Subscribe

Documents & Links